Daniel Lai
Affiliations: | 2014-2016 | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Google:
"Daniel Lai"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Funnell T, O'Flanagan CH, Williams MJ, et al. (2022) Single-cell genomic variation induced by mutational processes in cancer. Nature |
| Cochrane DR, Campbell KR, Greening K, et al. (2020) Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours. The Journal of Pathology |
| Ennishi D, Healy S, Bashashati A, et al. (2020) TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma. Nature Medicine |
| Laks E, McPherson A, Zahn H, et al. (2019) Clonal Decomposition and DNA Replication States Defined by Scaled Single-Cell Genome Sequencing. Cell. 179: 1207-1221.e22 |
| O'Flanagan CH, Campbell KR, Zhang AW, et al. (2019) Dissociation of solid tumor tissues with cold active protease for single-cell RNA-seq minimizes conserved collagenase-associated stress responses. Genome Biology. 20: 210 |
| Zhang AW, O'Flanagan C, Chavez EA, et al. (2019) Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling. Nature Methods |
| Campbell KR, Steif A, Laks E, et al. (2019) clonealign: statistical integration of independent single-cell RNA and DNA sequencing data from human cancers. Genome Biology. 20: 54 |
| Ennishi D, Takata K, Beguelin W, et al. (2019) Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition. Cancer Discovery |
| Pilsworth JA, Cochrane DR, Neilson S, et al. (2019) Abstract GMM-047: GENOMIC CHARACTERIZATION OF ADULT-TYPE GRANULOSA CELL TUMORS: IMPLICATIONS FOR PATHOGENESIS AND TREATMENT OF RECURRENT DISEASE Clinical Cancer Research. 25 |
| Healy S, Ennishi D, Bashashati A, et al. (2019) Abstract 3480:TMEM30Aloss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma Cancer Research. 79: 3480-3480 |